Jonathan Yong

Stock Analyst at UBS

(2.64)
# 2,011
Out of 4,853 analysts
104
Total ratings
60%
Success rate
10.49%
Average return

Stocks Rated by Jonathan Yong

eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5$7
Current: $4.40
Upside: +59.09%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.08
Upside: +29.87%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $14.15
Upside: +62.54%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33$25
Current: $23.17
Upside: +7.92%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33$30
Current: $11.25
Upside: +166.67%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15$12
Current: $10.62
Upside: +12.99%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7$8
Current: $4.01
Upside: +99.50%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27$26
Current: $12.86
Upside: +102.18%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $53.61
Upside: -73.89%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $70.36
Upside: +36.44%
Maintains: Neutral
Price Target: $29$32
Current: $15.24
Upside: +109.97%
Maintains: Outperform
Price Target: $115$105
Current: $20.05
Upside: +423.69%
Maintains: Outperform
Price Target: $76$80
Current: $121.27
Upside: -34.03%
Maintains: Outperform
Price Target: $247$231
Current: $254.37
Upside: -9.19%
Reiterates: Neutral
Price Target: $101
Current: $94.61
Upside: +6.75%
Reiterates: Neutral
Price Target: $27
Current: $7.12
Upside: +279.21%
Maintains: Neutral
Price Target: $90$100
Current: $154.07
Upside: -35.09%
Maintains: Outperform
Price Target: $430$450
Current: $709.46
Upside: -36.57%
Maintains: Neutral
Price Target: $15$12
Current: $3.56
Upside: +237.55%
Maintains: Neutral
Price Target: $80$70
Current: $6.92
Upside: +911.56%
Maintains: Neutral
Price Target: $14$17
Current: $14.26
Upside: +19.26%
Maintains: Outperform
Price Target: $347$350
Current: $292.61
Upside: +19.61%
Maintains: Outperform
Price Target: $93$95
Current: $22.60
Upside: +320.35%
Maintains: Underperform
Price Target: $7$8.5
Current: $5.91
Upside: +43.82%
Reiterates: Outperform
Price Target: $41
Current: $23.02
Upside: +78.11%
Maintains: Neutral
Price Target: $20$17
Current: $6.66
Upside: +155.26%
Maintains: Neutral
Price Target: $3.3$8.5
Current: $3.83
Upside: +121.93%
Reiterates: Outperform
Price Target: $85
Current: $78.06
Upside: +8.89%
Maintains: Neutral
Price Target: $143$146
Current: $173.81
Upside: -16.00%
Maintains: Outperform
Price Target: $104$106
Current: $54.94
Upside: +92.94%
Maintains: Outperform
Price Target: $129$157
Current: $188.65
Upside: -16.78%
Maintains: Outperform
Price Target: $329$368
Current: $310.12
Upside: +18.66%
Maintains: Outperform
Price Target: $548$635
Current: $230.83
Upside: +175.09%
Maintains: Outperform
Price Target: $113$117
Current: $63.57
Upside: +84.05%
Maintains: Outperform
Price Target: $31$30
Current: $13.90
Upside: +115.83%
Maintains: Outperform
Price Target: $267$298
Current: $381.66
Upside: -21.92%
Maintains: Outperform
Price Target: $88$95
Current: $169.89
Upside: -44.08%
Maintains: Outperform
Price Target: $462$495
Current: $300.38
Upside: +64.79%